We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Stem Cell Production Facility Installs CompacT SelecT™
News

New Stem Cell Production Facility Installs CompacT SelecT™

New Stem Cell Production Facility Installs CompacT SelecT™
News

New Stem Cell Production Facility Installs CompacT SelecT™

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "New Stem Cell Production Facility Installs CompacT SelecT™"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Automation Partnership (TAP) has announced that Stem Cell Sciences (SCS) has installed a CompacT SelecT™, automated cell culture system at its new facility in Cambridge, UK.

The CompacT SelecT at SCS will be used to culture several different human and mouse stem cell lines to supply the world’s top pharmaceutical companies with the right quantity, as well as quality of cells in assay ready plates.

According to TAP, Compact SelecT is ideal for growing high quality stem cells because it can maintain cells in a consistent environment. The system’s action and flexible robotic arm coupled with its software ensures cells can be processed on demand and left unattended, even at night or over weekends.

Julie Kerby, Business Unit Manager at SCS explained: “Stem cells are harder to grow than most cell lines so you have to reproduce their optimum growth conditions every time. We are confident the CompacT SelecT can do this because it is based on TAP’s SelecT cell culture system, which deservedly has the reputation of being the pharma industry’s gold standard for reliable automated cell culturing.”

Phil Offin, Cell Culture Product Manager at TAP added: “We are delighted to have such a major supplier of stem cells invest in a CompacT SelecT.  SCS’s astute decision will ensure top pharmas (with a SelecT) now have the flexibility to either obtain SCS’s quality assured cells on time, in their preferred format, or since CompacT SelecT and SelecT share the same sophisticated technology, they can confidently in-licence the cells to grow in house, because transferring proven production protocols will be rapid and reliable.”

Advertisement